Lexaria Bioscience Corp. Revenue From Contract With Customer Excluding Assessed Tax

Quick Answer

Lexaria Bioscience Corp. reported Revenue From Contract With Customer Excluding Assessed Tax of $384.5 thousand for the year ending 2020.

  • Lexaria Bioscience Corp. showed an increase of +72.7% in Revenue From Contract With Customer Excluding Assessed Tax from 2019 to 2020.
  • This data is from Lexaria Bioscience Corp.'s annual report (Form 10-K), filed with the SEC on October 15, 2020.
  • XBRL data for this metric is available from 2018 to 2020 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2018 to 2020), Lexaria Bioscience Corp.'s Revenue From Contract With Customer Excluding Assessed Tax has declined by 11.2%.
  • Historical annual values: Fiscal year 2020: $384.5 thousand | Fiscal year 2019: $222.6 thousand | Fiscal year 2018: $433.3 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: